In recent advancements in biomedical engineering, researchers have developed an innovative technique that significantly enhances deep tissue imaging and cell control in murine models. This groundbreaking study, published on August 1, 2025, in the journal Nature Communications, describes methods to increase the presence of a light-sensitive molecule, biliverdin, throughout the organism, thereby improving the efficacy of optogenetic applications.

Enhancements in Deep Tissue Imaging

The research team, comprised of biomedical and genetic engineers from Duke University and the Albert Einstein College of Medicine, aims at revolutionizing our imaging capabilities by utilizing biliverdin's properties, specifically its ability to absorb near-infrared (NIR) light. Traditional imaging methods are often hampered by limited tissue penetration, typically not exceeding one millimeter. The incorporation of biliverdin allows for imaging depths up to seven millimeters, exceeding previous limitations.

Method Depth of Tissue Penetration Resolution
Traditional Imaging Up to 1 mm Standard Resolution
Biliverdin-Enhanced Imaging Up to 7 mm 2-3 Times Greater Clarity

Mechanism of Action

Biliverdin is a naturally occurring biomolecule that is predominantly found in blood-rich organs such as the liver and spleen. However, its presence in the brain is limited due to the blood-brain barrier. To circumvent this, researchers silenced the enzyme biliverdin reductase-A, responsible for converting biliverdin into bilirubin. This manipulation resulted in a systemic increase of biliverdin levels, facilitating deeper and improved imaging capabilities.

“This technique has significant implications for enhancing our understanding of complex biological processes and diseases,” – Dr. Vladislav Verkhusha, Co-director of the Gruss-Lipper Biophotonics Center.

Applications in Diabetes Management

Beyond imaging, the enhanced levels of biliverdin afford researchers new avenues for therapeutic intervention. In a pivotal proof-of-concept study, the team employed this technique to stimulate insulin production in a knockout mouse model of type 1 diabetes. By applying NIR light, they managed to induce the liver to synthesize insulin, resulting in a remarkable 60% reduction in blood glucose levels.

Application Outcome
Stimulation of Insulin Production Reduced blood glucose levels by 60%
Deep Tissue Imaging Enhanced visualization of neuronal activity

Future Directions

The implications of this research extend far beyond the current findings, with potentials for future investigations including:

  • Development of targeted therapies: Explore the use of optogenetic tools to induce the liver to generate various therapeutic proteins.
  • Long-term disease studies: Utilize the established models to investigate neurodegenerative diseases and strokes using advanced imaging techniques.
  • Safety of Silencing Biliverdin Reductase-A: Ongoing studies to establish the long-term safety of this method in humans.

As researchers continue to explore these promising avenues, the collaborative efforts between Dr. Junjie Yao and Dr. Vladislav Verkhusha can potentially lead to significant breakthroughs in both imaging and therapeutic strategies.

Conclusion

The innovative use of biliverdin in enhancing imaging techniques and cellular control indicates a promising path forward for biomedical research. The ability to visualize deep tissue structures and modulate cellular behavior noninvasively opens exciting new doors for both diagnostics and therapeutic applications.

More Information: Ludmila A. Kasatkina et al., "Deep-tissue high-sensitivity multimodal imaging and optogenetic manipulation enabled by biliverdin reductase knockout," Nature Communications (2025).

This article is available online at Medical Xpress.

Journal Information: Peer-reviewed and published under the guidelines established by Nature Communications.